Antimicrobial resistance (AMR) is not just a looming health crisis — it is already a deadly reality. It demands urgent, coordinated, and sustained action across healthcare, agriculture, and food systems to protect communities in Asia.

A new study by the Centre for Impact Investing and Practices (CIIP) and the World Economic Forum’s GAEA (Giving to Amplify Earth Action) initiative, supported by the Philanthropy Asia Alliance (PAA), urges cross-sector investment to tackle the growing AMR threat in Asia.

The Targeted Action and Financing the Fight Against Antimicrobial Resistance in Asia report outlines four high-impact intervention areas to guide funders and partners:

• Sprint 1: Educate — Improving knowledge and behaviour by strengthening awareness of AMR among clinicians, patients, and farmers; emphasising the importance of avoiding the overuse or abuse of antimicrobials; as well as introducing strategies to prevent infections in the first place.
• Sprint 2: Prevent — Strengthening health systems and services by boosting preventive measures such as improving diagnostic capabilities and investing in better water, sanitation, and hygiene (WASH) measures.
• Sprint 3: Monitor — Enhancing regional surveillance, and data collection and sharing between actors, especially in lower-income countries.
• Marathon: Treat — Investing in research and development for new antimicrobials, and increasing access to novel and essential medicines.
  
  

Access the full report here. 

Catalytic funders have an important role to play in helping build better health systems and infrastructure, enhance education, and cultivate skilled talent.

To tackle AMR sustainably, a “One Health” approach — which recognises the interconnectedness and interdependence across humans, animals, plants, and the wider environment — is essential.

The report draws on insights from 15 case studies and examples of funding mechanisms, and contributions from 26 organisations, including international organisations, corporations, philanthropic funders, public institutions, and solution providers.

CIIP is a non-profit entity established by Temasek Trust in 2022 to foster impact investing and practices in Asia and beyond. It aims to contribute towards a sustainable future for all.

PAA is a Temasek Trust initiative dedicated to catalysing collaborative philanthropy in Asia through dynamic multi-sector partnerships.

For the latest on the Temasek Trust ecosystem, subscribe to our Impact Brief newsletter and follow us on LinkedIn, Instagram, Facebook, TikTok, and YouTube.